Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
25.0%
% of PBE's 28 holdings also in IDNA
15.6%
% of IDNA's 49 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 5.5% | 4.8% | 4.8% |
|
REGENERON PHARMACEUTICALS | 5.4% | 4.6% | 4.6% |
|
INCYTE CORP | 5.1% | 4.4% | 4.4% |
|
EXELIXIS INC | 3.1% | 4.7% | 3.1% |
|
DYNAVAX TECHNOLOGIES CORP | 2.4% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to IDNA
|
ILLUMINA INC | 5.7% |
|
BIOMARIN PHARMACEUTICAL INC | 5.4% |
|
AMGEN INC | 4.9% |
|
VERTEX PHARMACEUTICALS INC | 4.9% |
|
NEUROCRINE BIOSCIENCES INC | 4.0% |
|
HALOZYME THERAPEUTICS INC | 3.6% |
|
VERACYTE INC | 3.6% |
|
TG THERAPEUTICS INC | 3.4% |
|
UNITED THERAPEUTICS CORP | 3.3% |
|
IONIS PHARMACEUTICALS, INC. | 3.1% |
PBE Underweight Relative to IDNA
 |
ROCHE HOLDING LTD | -4.9% |
 |
BEIGENE, LTD. | -4.8% |
 |
SANOFI-AVENTIS | -4.4% |
|
SAREPTA THERAPEUTICS INC | -4.3% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.3% |
|
REVOLUTION MEDICINES, INC. | -4.2% |
 |
GSK PLC | -4.1% |
 |
GENMAB A/S | -3.9% |
|
MERCK & CO. INC. | -3.6% |
 |
BIONTECH SE SPONSORED ADR | -3.5% |